Ciwujia Capsules/Compound Ciwujia Granules in the Treatment of Insomnia

The goal of this real-world study is to investigate the efficacy and safety of "Ciwujia Capsules/Compound Ciwujia Granules" in the treatment of insomnia in the clinical real-world. A total of 40000 patients with insomnia are assigned to 8 weeks of Ciwujia Capsules/Compound Ciwujia Granules treatment. The main question it aims to answer is: 1. Is there any significant reduction in Pittsburgh Sleep Quality Index (PSQI) score, Insomnia Severity Index (ISI) score, subjective sleep latency, sedatives or hypnotics use, and improvement in sleep maintenance after 8 weeks treatment of Ciwujia Capsules/Compound Ciwujia Granules? 2. Is Ciwujia Capsules/Compound Ciwujia Granules" a safe method for treating insomnia in adults?

NCT Number	NCT07286838
Lead Sponsor	Hui Zhu Collaborators: Huazhong University of Science and Technology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions	Insomnia Disorders
Enrollment	40,000 participants
Start Date	2026-01-01
Primary Completion	2028-03-01 (estimated)
Study Completion	2028-06-01 (estimated)
Updated on ClinicalTrials.gov	2025-12-16